Prevalence Of Extended-Spectrum Beta-Lactamase Production In Clinical Escherichia Coli Isolates In Ibadan Metropolis, South-West Nigeria

Simple item page
dc.contributor.authorDUROWAIYE, MOJIRAYO T.
dc.contributor.authorADEWUYI, O.
dc.date.accessioned2023-06-27T14:37:16Z
dc.date.available2023-06-27T14:37:16Z
dc.date.issued2017
dc.descriptionEscherichia coli is a major extended spectrum beta-lactamase-producing organism. Extended spectrum beta-lactamases (ESBLs) inactivate newer cephalosporins through hydrolysis increasing therapeutic failure and antibiotic resistance worldwide. This experimental study determined the antibiotic susceptibility profile and ESBL production by clinical E. coli isolates. Majority of the clinical isolates of E. coli were ESBL producers which are resistant to frequently used antibiotics. K
dc.description.abstractIntroduction; Materials and Methods; Results; Conclusion, Recommendations ;References.
dc.identifier.issn0189-8434
dc.identifier.urihttps://nigeriareposit.nln.gov.ng/handle/20.500.14186/756
dc.language.isoen
dc.publisherDepartment of Pharmaceutical Microbiology, University of Ibadan Nigeria, Ibadan
dc.titlePrevalence Of Extended-Spectrum Beta-Lactamase Production In Clinical Escherichia Coli Isolates In Ibadan Metropolis, South-West Nigeria
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Durowaiye and Adewuyi.pdf
Size:
875.37 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.82 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Articles